Elanco Animal Health (ELAN) Exchange Rate Effect (2017 - 2026)
Elanco Animal Health (ELAN) reported Exchange Rate Effect of -$5.0 million for Q1 2026, down 117.24% on a YoY basis from $29.0 million in Q1 2025, and down 135.71% sequentially from $14.0 million in Q4 2025.
Elanco Animal Health (ELAN) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Exchange Rate Effect data on file, last reported at -$5.0 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 117.24% year-over-year to -$5.0 million; the trailing twelve-month figure through Mar 2026 stood at $37.0 million (up 186.05% YoY), and the FY2025 full-year result was $71.0 million, up 178.02% from the prior year.
- Exchange Rate Effect retreated to -$5.0 million in Q1 2026, from $14.0 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $32.0 million in Q4 2022 to a low of -$77.0 million in Q4 2024.
- A 5-year average of -$3.4 million and a median of -$3.0 million in 2023 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect tumbled 1800.0% in 2024 and jumped 1000.0% in 2025, its largest moves.
- Tracing ELAN's Exchange Rate Effect over 5 years: stood at $32.0 million in 2022, then tumbled by 109.38% to -$3.0 million in 2023, then slumped by 2466.67% to -$77.0 million in 2024, then surged by 118.18% to $14.0 million in 2025, then tumbled by 135.71% to -$5.0 million in 2026.
- Business Quant data shows ELAN's Exchange Rate Effect at -$5.0 million in Q1 2026, $14.0 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.00 Mn |
| Mar 31, 2026 | -5.00 Mn |
| Dec 31, 2025 | 14.00 Mn |
| Dec 31, 2025 | 14.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 27.00 Mn |
| Jun 30, 2025 | 27.00 Mn |
| Mar 31, 2025 | 29.00 Mn |
| Mar 31, 2025 | 29.00 Mn |
| Dec 31, 2024 | -77.00 Mn |
| Dec 31, 2024 | -77.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | -3.00 Mn |
| Jun 30, 2024 | -3.00 Mn |
| Mar 31, 2024 | -19.00 Mn |
| Mar 31, 2024 | -19.00 Mn |
| Sep 30, 2023 | -3.00 Mn |
| Sep 30, 2023 | -3.00 Mn |